Pediatric Phase 1/Pilot Consortium (U01)

The summary for the Pediatric Phase 1/Pilot Consortium (U01) grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.
Pediatric Phase 1/Pilot Consortium (U01): The purpose of the Request for Applications (RFA) reissuance is to continue NCI s program for the development of new anticancer agents for pediatric patients through the Children s Oncology Group (COG) Phase 1/Pilot Consortium. The Consortium will be responsible for timely conduct of the Phase 1 and pilot studies that are essential to NCI s overall clinical research program for children with cancer. This limited competition RFA for the renewal of U01 CA097452 solicits a single application from the Phase 1/Pilot Consortium of the Children s Oncology Group (COG) to continue its drug development activities. The specific objectives for the Consortium in the anticipated 5-year funding period will be: to safely and efficiently introduce novel anticancer agents into the pediatric setting through the conduct of Phase 1 clinical trials; to collaborate with COG Disease Committees to develop and conduct pilot studies of promising new treatment approaches for children with specific types of cancer; and to incorporate pharmacokinetic and pharmacodynamic endpoints (including imaging and translational laboratory studies) as appropriate into Phase 1 and pilot studies to facilitate future development of the new treatment approaches.
Federal Grant Title: Pediatric Phase 1/Pilot Consortium (U01)
Federal Agency Name: National Institutes of Health
Grant Categories: Health Education
Type of Opportunity: Discretionary
Funding Opportunity Number: RFA-CA-07-502
Type of Funding: Cooperative Agreement
CFDA Numbers: 93.395
CFDA Descriptions: Cancer Treatment Research
Current Application Deadline: No deadline provided
Original Application Deadline: Dec 01, 2006
Posted Date: Sep 08, 2006
Creation Date: Sep 08, 2006
Archive Date: Dec 31, 2006
Total Program Funding: $3,305,000
Maximum Federal Grant Award:
Minimum Federal Grant Award:
Expected Number of Awards:
Cost Sharing or Matching: No
Applicants Eligible for this Grant
Others (see text field entitled "Additional Information on Eligibility" for clarification)
Additional Information on Eligibility
Foreign institutions are not eligible to apply. The eligibility to apply in response to this limited competition RFA is limited to the current recipient of the Children s Oncology Group Phase 1/Pilot Consortium award under U01 CA097452.
Link to Full Grant Announcement
http://grants.nih.gov/grants/guide/rfa-files/RFA-CA-07-502.html http://grants.nih.gov/grants/guide/rfa-files/RFA-CA-07-502.html
Grant Announcement Contact
NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV
FBOWebmaster@OD.NIH.GOV If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster
Similar Government Grants
Specialized Programs of Research Excellence (SPOREs) in Human Cancers for Years 2015 and 2...
Pediatric Preclinical Testing Consortium: Coordinating Center (U01)
Pediatric Preclinical Testing Consortium: Research Programs (U01)
Planning for a National Center for Particle Beam Radiation Therapy Research (P20)
Limited Competition: Adult Brain Tumor Consortium (ABTC) (UM1)
Breast and Prostate Cancer Data Quality and Patterns of Care Study
Consortium Therapeutic Studies of Primary Central Nervous System Malignancies in Adults
National Cooperative Drug Discovery Groups for Cancer
More Grants from the National Institutes of Health
Family and Interpersonal Relationships in an Aging Context (R01)
Administrative Supplements for Tobacco Regulatory Research on the Public Display of Harmfu...
Targeting Persistent HIV Reservoirs (TaPHIR) (R21/R33)
BRAIN Initiative: Development and Validation of Novel Tools to Analyze Cell-Specific and C...
Research Aimed at Novel Behavioral Targets to Improve Adolescent Substance Abuse Treatment...

FederalGrants.com is not endorsed by, or affiliated with, any government agency. Copyright ©2014 FederalGrants.com